CRISPR-Cas9 Craze: exploring neurodegenerative disorders, Rudolf Jaenisch
Posted by btwatson on January 26, 2018 4:43 am
Tags:
Categories:
Crispr
CRISPR-Cas9 Craze: exploring neurodegenerative disorders, Rudolf Jaenisch
During this interview, Rudolf Jaenisch (MIT) presents his research focused on understanding the epigenetic regulation of gene expression in Cancer, during brain development or Parkinson’s disease.
Crispr News
-
ERS Genomics and NUVISAN ICB Sign CRISPR/Cas9 License Agreement - Business WireApril 19, 2021
-
New "Time Machine" Technique To Measure Cells Unveiled - Technology NetworksApril 19, 2021
-
Emerging Trend: Gene Editing Service Market Business Strategy and Forecast to 2026 | Caribou Biosciences,CRISPR Therapeutics,Merck KGaA – The Courier - The CourierApril 19, 2021
-
Global Crispr And Crispr-Associated (Cas) Genes Market Professional Report 2020 Witness Robust Expansion by 2025 - Clark County BlogApril 19, 2021
-
GE probiotic? CRISPR-edited yeast produce vitamin A precursor beta-carotene - Genetic Literacy ProjectApril 19, 2021
-
CRISPR: Can we control it? - Big ThinkApril 18, 2021
-
Technological Trends in CRISPR/Cas9 Market by 2021-2027 – Los Hijos de la Malinche - Los Hijos de la MalincheApril 17, 2021
-
‘The Code Breaker’ review: The quest to rewrite DNA - The HinduApril 17, 2021
-
CRISPR Gene Editing Tools Market to See Strong Expansion Through 2027 Covid-19 Analysis – KSU | The Sentinel Newspaper - KSU | The Sentinel NewspaperApril 17, 2021
-
CRISPR Stocks: The Big Analyst Call Destroying CRSP, NTLA, EDIT Stocks Today - NasdaqApril 16, 2021
-
Reversible CRISPR: An on-off switch for gene editing - ScienceBlog.comApril 16, 2021
-
Global CRISPR Genome Editing Market SWOT Analysis, Key Indicators, Forecast 2027 : Editas Medicine, CRISPR Therapeutics AG – The Courier - The CourierApril 16, 2021
-
Precision’s itinerant Car-T cells go on another journey - VantageApril 16, 2021
-
CRISPR Technology Market Restraints, Overview Highlighting Major Drivers, Trends, Growth and Demand Report 2020- 2027 – KSU | The Sentinel Newspaper - KSU | The Sentinel NewspaperApril 16, 2021
-
Crispr And Cas Genes Market to Grow with Sustainable CAGR During 2020 – 2027 | Key Players – CRISPR Therapeutics, Genscrip, AstraZeneca. – KSU | The Sentinel Newspaper - KSU | The Sentinel NewspaperApril 16, 2021
- CRISPR rivals put patents aside to help in fight against Covid-19 – STAT
- CRISPR 2.0: Base Editing in the Groove – Genetic Engineering & Biotechnology News
- The Promises of CRISPR Genome Editing in Biomedicine – Labiotech.eu
- The Code Breaker and Crispr People — the ethics of editing humanity – Financial Times
- ERS Genomics Licenses CRISPR Patents to CRO ZeClinics – GenomeWeb
- The Dark Side of CRISPR – Scientific American
- ERS Genomics and ZeClinics Sign CRISPR/Cas9 License Agreement – BioSpace
- Scientists Use CRISPR To Create Model of AML Progression – AJMC.com Managed Markets Network
- DECODR app identifies DNA mutations from CRISPR gene therapies – European Pharmaceutical Review
- CRISPR/Cas technology as a promising weapon to combat viral infections – Wiley
- Neanderthal-like ‘mini-brains’ created in lab with CRISPR – Nature.com
- Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – Phys.org
- Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – EurekAlert
- New CRISPR tech targets human genome’s complex code: Programmable CRISPR/Cas9-based kinase offers insights into, control over regulatory histone proteins – Science Daily
- After ditching Editas, AbbVie taps Caribou for new CRISPR, CAR-T pact – FierceBiotech
Leave a Reply
You must be logged in to post a comment.